Clinical Trial Update: Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial update for Nefecon in adults with primary IgA nephropathy reports efficacy and safety outcomes; results have been posted following completion of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Nefecon (nefecon)

Snippet

Sponsor: Calliditas Therapeutics AB | Conditions: Primary IgA Nephropathy | Phase 3 | Status: COMPLETED | Results posted: 2024-12-03